OMX Copenhagen 20
2.020,11
PKT
-307,38
PKT
-13,21
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.10.23 | A.P. Moeller - Maersk A-S (B) Sell | Deutsche Bank AG | |
13.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
08.09.23 | Novo Nordisk Overweight | Barclays Capital | |
07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.09.23 | Novo Nordisk Sell | UBS AG | |
05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
04.09.23 | Novo Nordisk Overweight | Barclays Capital | |
30.08.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
11.08.23 | Novo Nordisk Overweight | Barclays Capital | |
11.08.23 | Novo Nordisk Sell | UBS AG | |
11.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
10.08.23 | Novo Nordisk Overweight | Barclays Capital | |
10.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
09.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
09.08.23 | Novo Nordisk Sell | UBS AG | |
08.08.23 | Novo Nordisk Overweight | Barclays Capital | |
08.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
07.08.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
07.08.23 | A.P. Moeller - Maersk A-S (B) Sell | Goldman Sachs Group Inc. | |
03.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
27.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.07.23 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
12.07.23 | Novo Nordisk Sell | UBS AG | |
12.07.23 | Novo Nordisk Buy | Deutsche Bank AG | |
11.07.23 | Novo Nordisk Outperform | Credit Suisse Group | |
05.07.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
28.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
27.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
27.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
26.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
26.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. |